FGFR3 and plasma cell myeloma: The International Myeloma Working Group [82] and the European myeloma network [83] state that the minimum testing required is determination of TP53 deletion and presence of a t(4;14)(p16;q32);FGFR3/MMSET-IGH gene rearrangement.